A 28-year-old man with otosclerosis presents with progressive conductive hearing loss and tinnitus. He has declined surgical intervention and wishes to try medical therapy. Which of the following is the preferred first-line pharmacological agent to slow disease progression?

Explanation

## First-Line Medical Therapy for Otosclerosis **High-Yield:** Sodium fluoride combined with calcium supplementation is the ONLY established first-line medical treatment for otosclerosis with Level 1 evidence for slowing disease progression. ### Why Sodium Fluoride? **Key Point:** Sodium fluoride is the gold standard because it: 1. **Inhibits osteoclast-mediated bone resorption** in the otosclerotic focus 2. **Stimulates osteoblast activity**, promoting new bone formation 3. **Stabilizes stapes fixation**, slowing progression of hearing loss 4. Has **decades of clinical evidence** supporting efficacy ### Standard Regimen ``` Sodium fluoride: 20 mg daily (or 40 mg alternate days) + Calcium carbonate: 1000–1500 mg daily (divided doses) + Vitamin D: 400–800 IU daily (to enhance calcium absorption) Duration: 2–3 years with 6-monthly audiological review ``` ### Why Other Options Are Not First-Line | Agent | Reason for Non-Use | | --- | --- | | Bisphosphonates (alendronate) | No proven efficacy in otosclerosis; used for osteoporosis, not otosclerotic bone remodeling | | Vitamin D alone | Insufficient as monotherapy; only supportive role with calcium in fluoride regimen | | NSAIDs | No evidence for slowing otosclerotic progression; may be used for symptom relief only | **Clinical Pearl:** Bisphosphonates inhibit both osteoclasts AND osteoblasts, making them unsuitable for otosclerosis, which requires active osteoblastic bone formation to stabilize the lesion. ### Monitoring During Sodium Fluoride Therapy 1. **Audiometry** — every 6 months to document stabilization 2. **Serum calcium** — baseline and annually (target: 8.5–10.5 mg/dL) 3. **Serum phosphate** — annually 4. **Renal function** — baseline and annually (fluoride clearance) 5. **Compliance assessment** — ensure calcium is taken separately from fluoride (2-hour gap) **Warning:** Hypocalcemia is a serious complication if calcium supplementation is omitted. Symptoms include perioral paresthesias, muscle cramps, and tetany. ### When to Switch to Surgery - Failure of hearing stabilization after 2–3 years of therapy - Rapid progression despite medical management - Patient preference for definitive treatment - Bilateral disease affecting quality of life